Inadvertent IM injection can lead to unpredictable insulin absorption and variable effects on glucose and is associated with frequent and unexplained hypoglycemia
A capsule becomes part of the morning routine, something that promises energy, recovery, or metabolic support
It is a semaglutide like Ozempic and Wegovy, but it does not need to be injected
As identified by the FDA, the Federal Bureau of Investigation, and many state Attorneys General, key areas for enforcement are sellers using online app-based platforms to supply consumers with GLP-1 products containing insulin or animal grade ingredients and illegally selling the active pharmaceutical ingredient (API) in GLP-1s directly to consumers
Individuals with metabolic conditions: Fatty liver disease and prediabetes are just two of the various metabolic red flags that GLP-1 medications can effectively address
It is legally available only for scientific studies and research purposes in the United States